Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul;16(3):338-41.
doi: 10.4103/0972-2327.116918.

Congenital myasthenic syndromes: Natural history and long-term prognosis

Sujit Abajirao Jagtap  1 , Kuruvilla Abraham, C Sarada, M D Nair
Affiliations

Congenital myasthenic syndromes: Natural history and long-term prognosis

Sujit Abajirao Jagtap et al. Ann Indian Acad Neurol. 2013 Jul.

Abstract

Introduction: Congenital myasthenia syndrome (CMS) is a rare, heterogeneous group of genetically determined, disorder of neuromuscular transmission. They have a varied presentation and progression and very few studies have addressed the natural history. Aim of the present study is to describe the clinical profile and natural history of patients with CMS.

Materials and methods: Study includes patients with CMS who attended comprehensive-neuromuscular-clinic (CNMC) during the period January, 2000-2008 with a minimum follow-up of 2 years, with inclusion criteria: (1) Onset in infancy or childhood with fluctuating ocular, bulbar, respiratory or limb muscle weakness (2) Acetylcholine receptor antibody negative (3) normal computed tomography (CT) thymus (4) Abnormal repetitive nerve stimulation (RNS) testing (5) Exclusion of other autoimmune disorders.

Results: Out of 314 patients with myasthenia who attended the CNMC during study period, 15 (4.8%) were with CMS (8 boys, 7 girls). Patients were divided as infantile and childhood onset. The mean age of onset and diagnosis in infantile and childhood onset groups were 5.5 months/3.1 years and 3.6 years/6.5 years respectively. Eleven patients had ptosis and 4 had generalized presentation. Most common site of decremental response was over facial nerve in 12 (75%) patients. All patients showed good response to treatment with acetyl cholinesterase inhibitor with stable course on follow-up without exacerbations. Mean dose for neostigmine was 28 mg/day and for pyridostigmine was 153 mg/day.

Conclusion: Ptosis is most common symptom at onset in CMS, emphasing importance of RNS of the facial nerve, in the absence of molecular diagnosis of CMS. Our CMS cohort had relatively stable course without intermittent exacerbations with fair response to acetyl cholinesterase inhibitor.

Keywords: Acetylcholine receptor deficiency; congenital myasthenia syndrome; ocular myasthenia.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil

Figures

Figure 1
Figure 1
Patient with elongated face, low set ears and high-arched palate
See this image and copyright information in PMC

References

    1. Rothbart HB. Myasthenia gravis in children-its familial incidence. JAMA. 1937;108:715–7.
    1. Bowman JR. Myasthenia gravis in young children; report of three cases, one congenital. Pediatrics. 1948;1:472–7. - PubMed
    1. Ohno K, Tsujino A, Brengman JM, Harper CM, Bajzer Z, Udd B, et al. Choline acetyltransferase mutations cause myasthenic syndrome associated with episodic apnea in humans. Proc Natl Acad Sci U S A. 2001;98:2017–22. - PMC - PubMed
    1. Byring RF, Pihko H, Tsujino A, Shen XM, Gustafsson B, Hackman P, et al. Congenital myasthenic syndrome associated with episodic apnea and sudden infant death. Neuromuscul Disord. 2002;12:548–53. - PubMed
    1. Donger C, Krejci E, Serradell AP, Eymard B, Bon S, Nicole S, et al. Mutation in the human acetylcholinesterase-associated collagen gene, COLQ, is responsible for congenital myasthenic syndrome with end-plate acetylcholinesterase deficiency (Type Ic) Am J Hum Genet. 1998;63:967–75. - PMC - PubMed